Chinese medicine neuroaid efficacy on stroke recovery: A double-blind, placebo-controlled, randomized study

• Main Authors: Christopher L.H. Chen, Sherry H.Y. Young, Herminigildo H. Gan, Rajinder Singh, Annabelle Y. Lao, Alejandro C. Baroque, Hui Meng Chang, John Harold B. Hiyadan, Carlos L. Chua, Joel M. Advincula, Sombat Muengtaweepongsa, Bernard P.L. Chan, H. Asita De Silva, Somchai Towanabut, Nijasri C. Suwanwela, Niphon Poungvarin, Siwaporn Chankrachang, K. S.Lawrence Wong, Gaik Bee Eow, Jose C. Navarro, Narayanaswamy Venketasubramanian, Chun Fan Lee, Marie Germaine Bousser
• Format: Journal
• Published: 2018
• Subjects: Medicine; Nursing
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84880803598&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/52837
• Institution: Chiang Mai University

BACKGROUND AND PURPOSE-: Previous clinical studies suggested benefit for poststroke recovery when MLC601 was administered between 2 weeks and 6 months of stroke onset. The Chinese Medicine Neuroaid Efficacy on Stroke recovery (CHIMES) study tested the hypothesis that MLC601 is superior to placebo in...